Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy

The goal of this study was to explore the efficacy and safety of neoadjuvant chemoimmunotherapy followed by surgery and postoperative radioimmunotherapy in patients with locally advanced esophageal squamous cell carcinoma

Trial Details

NCT ID
NCT06602843
Phase
NA
Sponsor
Anhui Provincial Hospital
Status
RECRUITING
Cancer Type
Esophageal Cancer
Interventions
  • Neoadjuvant chemoimmunotherapy followed by surgery and postoperative radioimmunotherapy
Locations (sample)
  • Hefei, China|31.86389,117.28083

Key Eligibility Criteria

  • Ages 18-75;
  • Radical operation for esophageal cancer;
  • Esophageal squamous cell carcinoma was confirmed by postoperative pathology; . Preoperative imaging (enhanced cervical, thoracoabdominal CT+ bone s…
  • More than or equal to 12 lymph nodes were surgically removed;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Esophageal Cancer Trials on Trialify →